Ownership Summary
A total of 7 institutions have reported a stake in DNA X, Inc. (NASDAQ:SONM) as of December 2025, according to recent 13F filings with the SEC.
- The percentage of Dna X owned by institutions changed from 154.9% in September 2025 to 25.1% in December 2025, marking a slight down trend.
- Institutional share ownership changed by nan% QoQ, while the number of institutional owners saw a decrease of 36.36% YoY.
- A review of institutional activity for Dna X shows 7 of 7 filers increasing their positions, while 0 reduced their stake, and 0 remained unchanged.
- The aggregate institutional position in Dna X now stands at 84.53K shares as of December 2025, after investors increased their holdings (up by 84.53K shares quarter on quarter which is down 5.43K shares year over year).
- Potomac Capital Management, Inc. continues to be the largest institutional holder of Dna X as of December 31, 2025, with a position of 48.00K shares, representing 14.26% of the company's outstanding stock.
- Among the most significant buyers of Dna X during December 2025 were Potomac Capital Management, Inc. (48.00K), BlackRock, Inc. (14.01K), CANNELL CAPITAL LLC (13.63K), UBS Group AG (8.68K), SBI Securities Co., Ltd. (214).
- The top 7 institutional holders of Dna X for the quarter ending December 2025 included Potomac Capital Management, Inc. (48.00K), BlackRock, Inc. (14.01K), CANNELL CAPITAL LLC (13.63K), UBS Group AG (8.68K), SBI Securities Co., Ltd. (214), BANK OF AMERICA CORP /DE/ (4), BNP PARIBAS FINANCIAL MARKETS (1).